Expediting red blood cell transfusions by syringing causes significant hemolysis.
Willem Lambertus De Villiers, Adriaan Albertus Murray, Andrew Ian Levin
https://pubmed.ncbi.nlm.nih.gov/28833178/Actively Recruiting
Led by Aswan University · Updated on 2026-03-12
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the safety and effectiveness of two methods for blood transfusion in women experiencing major obstetric hemorrhage during cesarean sections. The study focuses on comparing manual syringing using 20 mL syringes and pneumatic pressure bags inflated to 300 mmHg. The main goals include assessing which method causes more red blood cell destruction hemolysis, which stabilizes vital signs faster, and differences in blood product usage, complications, and hospital stay length. The trial is a prospective, randomized controlled study conducted at a single center. Women aged 18 to 45 undergoing cesarean section with major hemorrhage are randomly assigned to receive blood transfusions via manual syringing or pneumatic pressure bags. All participants have vascular access through multiple cannulae and are closely monitored for vital signs and transfusion-related complications. Blood samples are collected at baseline and six hours after transfusion to check markers of hemolysis. Participants undergo continuous monitoring of blood pressure, heart rate, and oxygen levels to determine the time to hemodynamic stability. Researchers track transfusion complications during hospitalization and for 30 days after surgery. The study measures primary outcomes such as hemolysis incidence using laboratory markers and secondary outcomes including hemodynamic stability achievement, blood volume transfused, and complications. The total participation duration includes the treatment period and postoperative follow-up for safety.
CONDITIONS
Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric Hemorrhage
S
Soudy Hammad, lecturer of anesthesia,SICU,
T
Tarek Hemaida, lecturer
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Aswan University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 hours post transfusion
Participants undergo blood transfusion during cesarean section using either manual syringing with 20 mL syringes or pneumatic pressure bags inflated to 300 mmHg to manage major obstetric hemorrhage.
1 transfusion and monitoring period during cesarean section
Duration - Up to 6 hours post transfusion
Participants are monitored for safety outcomes including hemolysis markers and hemodynamic stability for up to 6 hours after transfusion.
Blood samples at baseline and 6 hours post transfusion; continuous monitoring during this period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Willem Lambertus De Villiers, Adriaan Albertus Murray, Andrew Ian Levin
https://pubmed.ncbi.nlm.nih.gov/28833178/Kelly Cristina Sbampato Calado Orsi, Vanessa Yukie Kita, Adja Havreluk Paiva de Souza...
https://pubmed.ncbi.nlm.nih.gov/34726655/Aaron Jacob Grossberg, Daniel A Fowl, Brian T Merritt...
https://pubmed.ncbi.nlm.nih.gov/39911470/Rezan Abdul-Kadir, Claire McLintock, Anne-Sophie Ducloy...
https://pubmed.ncbi.nlm.nih.gov/24617726/Yoon Ji Choi, Hyub Huh, Go Eun Bae...
https://pubmed.ncbi.nlm.nih.gov/29995802/Aswan University
Lead Sponsor